Skip to content
pitch

UPC Case Law

Amgen, Inc v Sanofi-Aventis Deutschland GmbH and others

Decision of the UPC Court of Appeal of 25 November 2025, UPC CoA 528/2024

UPC Case Law by Pitch, edited by Bart Lieben · Published

TL;DR

The Court of Appeal overturned the Munich central division and upheld Amgen's PCSK9 antibody patent EP 3 666 797 against Sanofi and Regeneron, finding that the skilled person had no reasonable expectation of success that an antibody would be therapeutically effective. In doing so, the Court set out the UPC's own framework for inventive step, including the rule that the skilled person "would", not merely "could", have arrived at the invention, and who bears the burden of proof on expectation of success.

Key holding

Under Art 56 EPC, a claimed solution is obvious only if the skilled person, starting from a realistic starting point, would (and not only could) have reached it, typically because the result was clearly predictable or there was a reasonable expectation of success. The party asserting invalidity bears the burden of proving that expectation. Once the patentee substantiates uncertainties or practical difficulties, that party must also prove these would not have prevented a reasonable expectation of success. In a medical use claim, therapeutic efficacy is an inherent feature requiring a noticeable (meaningful) improvement of the patient's condition, not merely any measurable effect.

Questions decided

  1. What is the UPC test for inventive step, including reasonable expectation of success?
  2. Who bears the burden of proof on reasonable expectation of success?
  3. What level of therapeutic effect does a medical use claim implicitly require?
  4. Can dependent claims adding a separate feature inform interpretation of the main claim?
  5. May the Court examine the whole application when assessing added matter, regardless of the passages the parties cited?
  6. Does a functional antibody claim lack sufficiency because not every embodiment is enabled?

Full summary

Read the full analyses for free — create a free account

With a free Academy account you read the full analysis of every Court of Appeal decision: the facts and procedure, the issues, the court’s reasoning and the practice points. Your name, an e-mail address and a password; no payment, and you can delete the account yourself at any time.

Create an account

At least 12 characters. A few words in a row make a strong password that’s easy to remember.

Already have an account?

In the same case

More on validity and revocation

Validity and revocation →

← All Court of Appeal summaries

Let’s talk

Tell us what you’re working on. We’ll get the right person on it and reply within one business day. The first chat is free.

Schedule a meeting